Happiness.
It’s Our Mission.

SK pharmteco is a global contract development and manufacturing organization (CDMO) with 7 manufacturing facilities across the U.S., Europe, and Korea. The company partners with biopharmaceutical companies to manufacture Active Pharmaceutical Ingredients (API) and intermediates, cell and gene therapy technologies, registered starting materials, and to perform analytical services. SK pharmteco is a subsidiary of SK Inc. (KRX: 034730) (SK), the strategic investment company for SK Group, South Korea’s second-largest conglomerate.

SK pharmteco is a leader in operational excellence and continuous improvement. Our highly skilled team delivers innovative solutions utilizing advanced technologies:

• Energetic Chemistry
• Continuous Flow Processing
• Chromatography: Simulated Moving Bed (SMB) & Batch 
• High Potency (Up to 4 m3 scale & Down to 10 ng/m³ Containment) 
• Controlled Substances (Schedule II-V Manufacturing)
• Particle Engineering
• CGMP Manufacturing in Adherent & Suspension Systems for Viral Vectors
• CGT Process Development, Analysis, Plasmid DNA Manufacturing, and Cell Therapy Manufacturing
• Analytical & Process Development for Viral Vectors

We provide PAI and full regulatory support as well as complete confidentiality. We have a strong record of environmental, health, and safety performance. All our plants have been successfully audited by global regulatory agencies including the FDA (US), EMA (Europe), PMDA (Japan), and MFDS (Korea). 

With a strong technology toolbox and ~1,000 m³ (~265,000 gal) of global small molecule capacity and two facilities dedicated to large molecules, we have the capability and capacity to support your needs across the full lifecycle.